The growing interest in nanomedicine over the last 20 years has carved out a research field
called “nanocatalytic therapy,” where catalytic reactions mediated by nanomaterials are …

Normal circulatory function is a key determinant of disease-free life expectancy (healthspan).
Indeed, pathologies affecting the cardiovascular system, which are growing in prevalence …

Recent advances have greatly improved our understanding of the molecular mechanisms
behind atherosclerosis pathogenesis. However, there is still a need to systematize this data …

Atherosclerosis (AS), a leading cause of death worldwide, involves chronic macrophage
inflammation from its initiation to the emergence of complications. Targeting plaque …

The advent of single-cell biology opens a new chapter for understanding human biological
processes and for diagnosing, monitoring, and treating disease. This revolution now …

Exercise, stress, sleep and diet are four distinct but intertwined lifestyle factors that influence
the cardiovascular system. Abundant epidemiological, clinical and preclinical studies have …

Vascular cell adhesion molecule-1 (VCAM-1) has been well established as a critical
contributor to atherosclerosis and consequently as an attractive therapeutic target for anti …

Over the last decades, childhood and adolescence have emerged as an important window
of opportunity to prevent atherosclerotic cardiovascular disease (ASCVD) later in life. Here …

Accumulation of lipid-laden macrophages within the arterial neointima is a critical step in
atherosclerotic plaque formation. Here, we show that reduced levels of the cellular plasticity …

Cardiovascular disease is the leading cause of mortality and morbidity throughout the world,
accounting for 16.7 million deaths each year. The underlying pathological process for the …